Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grupos

Publicaciones

  • Maiques, O; Macia, A; Moreno, S; Barcelo, C; Santacana, M; Vea, A; Herreros, J; Gatius, S; Ortega, E; Valls, J; Chen, BJ; Llobet-Navas, D; Matias-Guiu, X; Canti, C; Marti, RM

    Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma

    BRITISH JOURNAL OF DERMATOLOGY 176 1247-1258. .

    [doi:10.1111/bjd.15121]

  • Piulats, JM; Guerra, E; Gil-Martin, M; Roman-Canal, B; Gatius, S; Sanz-Pamplona, R; Velasco, A; Vidal, A; Matias-Guiu, X

    Molecular approaches for classifying endometrial carcinoma

    GYNECOLOGIC ONCOLOGY 145 200-207. .

    [doi:10.1016/j.ygyno.2016.12.015]

  • Garcia-Sanz, P; Triviño JC; Mota, A; Perez Lopez, M; Colas, E; Rojo-Sebastian, A; Garcia, A; Gatius, S; Ruiz, M; Prat, J; Lopez-Lopez, R; Abal, M; Gil-Moreno, A; Reventos, J; Matias-Guiu, X; Moreno-Bueno, G

    Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma

    INTERNATIONAL JOURNAL OF CANCER 140 1551-1563. .

    [doi:10.1002/ijc.30573]

  • Mancikova, V; Montero-Conde, C; Perales-Paton, J; Fernandez, A; Santacana, M; Jodkowska, K; Inglada-Perez, L; Castelblanco, E; Borrego, S; Encinas, M; Matias-Guiu, X; Fraga, M; Robledo, M

    Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors

    CLINICAL CANCER RESEARCH 23 1334-1345. .

    [doi:10.1158/1078-0432.CCR-16-0947]

  • Devis, L; Moiola, CP; Masia, N; Martinez-Garcia, E; Santacana, M; Stirbat, TV; Brochard-Wyart, F; Garcia, A; Alameda, F; Cabrera, S; Palacios, J; Moreno-Bueno, G; Abal, M; Thomas, W; Dufour, S; Matias-Guiu, X; Santamaria, A; Reventos, J; Gil-Moreno, A; Colas, E

    Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer

    JOURNAL OF PATHOLOGY 241 475-487. .

    [doi:10.1002/path.4851]

  • Ruiz, N; Vidal, A; Ponce, J; Marti, L; Rovira, J; Barahona, M; Piulats, JM; Llobeta-Navas, D; Santacana, M; Villanueva, A; Matias-Guiu, X

    Patient-Derived Orthoxenografts (PDX) Reproduce Pathological Features of Corresponding Endometrial Carcinomas (EC)

    Modern Pathology 30 306-306. .

  • Ruiz, N; Vidal, A; Ponce, J; Marti, L; Rovira, J; Barahona, M; Piulats, JM; Llobeta-Navas, D; Santacana, M; Villanueva, A; Matias-Guiu, X

    Patient-Derived Orthoxenografts (PDX) Reproduce Pathological Features of Corresponding Endometrial Carcinomas (EC)

    LABORATORY INVESTIGATION 97 306-306. .

  • Bosse, T; Nout, RA; McAlpine, JN; McConechy, M; Britton, H; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Matias-Guiu, X; Gilks, B; Soslow, R

    Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

    Modern Pathology 30 277-277. .

  • Bosse, T; Nout, RA; McAlpine, JN; McConechy, M; Britton, H; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Matias-Guiu, X; Gilks, B; Soslow, R

    Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

    LABORATORY INVESTIGATION 97 277-277. .

  • Eritja, N; Chen, BJ; Rodriguez-Barrueco, R; Santacana, M; Gatius, S; Vidal, A; Marti, MD; Ponce, J; Bergada, L; Yeramian, A; Encinas, M; Ribera, J; Reventos, J; Boyd, J; Villanueva, A; Matias-Guiu, X; Dolcet, X; Llobet-Navas, D

    Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer

    Autophagy 13 608-624. .

    [doi:10.1080/15548627.2016.1271512]

  • Mota, A; Colas, E; Garcia-Sanz, P; Campoy, I; Rojo-Sebastian, A; Gatius, S; Garcia, A; Chiva, L; Alonso, S; Gil-Moreno, A; Gonzalez-Tallada, X; Diaz-Feijoo, B; Vidal, A; Ziober-Malinowska, P; Bobinski, M; Lopez-Lopez, R; Abal, M; Reventos, J; Matias-Guiu, X; Moreno-Bueno, G

    Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers

    Modern Pathology 30 134-145. .

    [doi:10.1038/modpathol.2016.143]

  • Eritja, N; Yeramian, A; Chen, BJ; Llobet-Navas, D; Ortega, E; Colas, E; Abal, M; Dolcet, X; Reventos, J; Matias-Guiu, X

    Endometrial Carcinoma: Specific Targeted Pathways

    Advances in Experimental Medicine and Biology 943 149-207. .

    [doi:10.1007/978-3-319-43139-0_6]

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU